112 related articles for article (PubMed ID: 26343823)
1. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
[TBL] [Abstract][Full Text] [Related]
2. Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF Guidelines.
Kyriakos G; Vidal-Casariesgo A; Quiles-Sánchez LV; Urosa-Maggi JA; Calleja-Fernández A; Hernández-Moreno A; Ballesteros-Pomar MD; Cano-Rodriguez I
Exp Clin Endocrinol Diabetes; 2016 Sep; 124(8):466-473. PubMed ID: 27219881
[No Abstract] [Full Text] [Related]
3. Impact on the population of different bone mineral density testing criteria and appropriateness of densitometries in the ESOSVAL cohort, Spain.
Hurtado I; Sanfélix-Gimeno G; Baixauli-Pérez C; Peiró S; Sanfélix-Genovés J
J Clin Endocrinol Metab; 2014 Jan; 99(1):142-50. PubMed ID: 24384018
[TBL] [Abstract][Full Text] [Related]
4. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.
Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I
Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the NOF and NOGG guidelines for spinal radiographic examination in postmenopausal Chinese women.
Chen R; Liu S; Huang M; Ding N; Wang Q; Xie Z; Liu H; Sheng Z; Ou Y
Arch Osteoporos; 2021 Jan; 16(1):5. PubMed ID: 33399996
[TBL] [Abstract][Full Text] [Related]
6. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
[TBL] [Abstract][Full Text] [Related]
7. Disparate outcomes from applying U.K. and U.S. osteoporosis treatment guidelines.
Bolland MJ; Grey A
J Clin Endocrinol Metab; 2010 Apr; 95(4):1856-60. PubMed ID: 20147581
[TBL] [Abstract][Full Text] [Related]
8. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
Silva DMW; Borba VZC; Kanis JA
Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
[TBL] [Abstract][Full Text] [Related]
10. Impact of UK National Guidelines based on FRAX®--comparison with current clinical practice.
Crabtree NJ; Bebbington NA; Chapman DM; Wahid YS; Ayuk J; Boivin CM; Cooper MS; Gittoes NJ;
Clin Endocrinol (Oxf); 2010 Oct; 73(4):452-6. PubMed ID: 20626412
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
Azagra Ledesma R; Prieto-Alhambra D; Encabo Duró G; Casado Burgos E; Aguyé Batista A; Díez-Pérez A;
Med Clin (Barc); 2011 May; 136(14):613-9. PubMed ID: 21349558
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of applying the NOF, NOGG and Taiwanese guidelines to a cohort of Chinese early postmenopausal women.
Cheung E; Kung AW; Tan KC
Clin Endocrinol (Oxf); 2014 Feb; 80(2):200-7. PubMed ID: 24010883
[TBL] [Abstract][Full Text] [Related]
13. Impact of FRAX-based osteoporosis intervention using real world data.
Goldshtein I; Ish-Shalom S; Leshno M
Bone; 2017 Oct; 103():318-324. PubMed ID: 28778597
[TBL] [Abstract][Full Text] [Related]
14. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
Hough S
S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
[TBL] [Abstract][Full Text] [Related]
15. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
[TBL] [Abstract][Full Text] [Related]
16. Choice of osteoporosis guideline has important implications for the treatment decision in elderly women referred to a fall clinic.
Thomsen K; Ryg J; Matzen L; Hermann AP; Masud T
Dan Med J; 2014 Dec; 61(12):A4980. PubMed ID: 25441734
[TBL] [Abstract][Full Text] [Related]
17. Treatment implications for men when switching from male to female bone mineral density reference data: the Manitoba Bone Density Program.
Leslie WD; Majumdar SR
J Clin Densitom; 2013; 16(4):537-42. PubMed ID: 24090643
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations of FRAX in clinical assessment of osteoporosis indicated in European and US guidelines].
Nakamura T
Clin Calcium; 2009 Dec; 19(12):1723-8. PubMed ID: 19949262
[TBL] [Abstract][Full Text] [Related]
19. FRAX without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older.
Pang WY; Inderjeeth CA
J Am Geriatr Soc; 2014 Mar; 62(3):442-6. PubMed ID: 24617899
[TBL] [Abstract][Full Text] [Related]
20. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
